Bangladesh to Remove Government Stake in Tobacco Company

Dec.28.2022
Bangladesh to Remove Government Stake in Tobacco Company
Bangladesh plans to remove government workers from the British American Tobacco Bangladesh committee to prevent interference in tobacco control policies.

Bangladesh's Planning Minister, M.A. Mannan, has suggested that government officials should leave the British American Tobacco Bangladesh Committee in order to prevent interference from the tobacco industry in the country's control policies and government initiatives.


The Bangladeshi government holds a small percentage of shares in British and American tobacco companies. MA Mannan, while organizing a meeting titled "Improving the Bangladesh Labor Welfare Trust Fund and Public Health Research and Communication Initiative" in the Planning Ministry, stated that he will request the Prime Minister to withdraw these shares.


Bangladesh legislator and senior lawyer Shamim Haider Patwari stated that their fight against tobacco is an unequal battle. He demands that the government divest its shares in tobacco companies.


At another event organized by the non-governmental think tank Unayan Shamannay in the capital of Bangladesh, speakers emphasized the need to strengthen tobacco control laws and ban smoking for the general public in order to fulfill the Prime Minister's vision of making Bangladesh a smoke-free country.


Furthermore, designated smoking areas, the depiction of smoking scenes in films subject to certain conditions, and tobacco companies' corporate social responsibility must be prohibited.


Atiur Rahman, former governor of the Central Bank of Bangladesh, has stated that policymakers have played a significant role not only in reducing tobacco consumption in Bangladesh but also in providing substantial support for anti-tobacco movements.


He added that citizens and decision-makers should work together to fulfill the Prime Minister's commitment through stricter tobacco control laws and proper implementation of the law.


According to Member of Parliament Fazle Hossain Badsha, there is a widespread perception that opposing tobacco leaves a negative impression. However, if tobacco control laws were strengthened, the dream of a smoke-free Bangladesh could be realized.


Another legislator, SM Shahzada, has stated that there has been a noticeable increase in tobacco use during the election campaign. He has called for necessary measures to be taken to break the tradition of using cigarettes to lure voters during the election.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Indonesian drug agency chief proposes ban on e-cigarettes and e-liquid containing harmful substances
Indonesian drug agency chief proposes ban on e-cigarettes and e-liquid containing harmful substances
Indonesian drug agency chief proposes ban on e-cigarette and e-liquid in new draft law, citing dangerous substances found.
Apr.08 by 2FIRSTS.ai
Imperial Tobacco Canada Responds to Anti-Smoking Groups on Youth Vaping
Imperial Tobacco Canada Responds to Anti-Smoking Groups on Youth Vaping
Imperial Tobacco Canada responded to the April 17 press conference by anti-smoking groups by calling for a more focused, fact-based discussion on youth vaping that targets the illicit market. The company said youth should not be using nicotine products and that it supports strong measures to prevent youth access, but argued that the discussion failed to clearly distinguish between the regulated market and the illicit market that is driving youth access.
Apr.22 by 2FIRSTS.ai
Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS
Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS
Altria Group reported its first-quarter 2026 results on April 30. Net revenues were $5.43 billion, up 3.2% year on year, while revenues net of excise taxes were $4.76 billion, up 5.3%. Reported diluted EPS was $1.30, up more than 100%, and adjusted diluted EPS was $1.32, up 7.3%.
May.06 by 2FIRSTS.ai
Special Report | PLONQ Expands in China With New Shenzhen Hub to Accelerate R&D and Partnerships
Special Report | PLONQ Expands in China With New Shenzhen Hub to Accelerate R&D and Partnerships
On March 27, 2026, PLONQ officially opened its upgraded Shenzhen office, reinforcing its long-term commitment to China and marking a new phase of growth. As a leading vape brand in Russia, PLONQ is expanding into new product categories while strengthening R&D, engineering collaboration, and partnerships with Chinese companies. The Shenzhen office will accelerate product development, enhance cooperation with technology and manufacturing partners, and support future growth initiatives.
Apr.01
FDA Renews Exposure Modification Authorization for IQOS Devices and Three HeatSticks Products
FDA Renews Exposure Modification Authorization for IQOS Devices and Three HeatSticks Products
U.S. Food and Drug Administration renewed modified risk granted orders for five IQOS products from Philip Morris Products S.A., including two IQOS system holders and chargers and three HeatSticks products. Under the renewed orders, the products may continue to be marketed with an exposure modification claim.
Apr.20 by 2FIRSTS.ai
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13